Safety Monitoring in Group A Meningococcal Conjugate Vaccine Trials: Description, Challenges, and Lessons | Zendy

Godwin Enwere | Zendy; Gandhali Paranjape | Zendy; Prasad S. Kulkarni | Zendy; Manisha Ginde | Zendy; Katharina Hartmann | Zendy; Simonetta Viviani | Zendy; Julie Chaumont | Zendy; Lionel Martellet | Zendy; Marie-Françoise Makadi | Zendy; Karen Ivinson | Zendy; Elisa Marchetti | Zendy; Jacques Hervé | Zendy; Kim Kertson | Zendy; F. Marc LaForce | Zendy; MariePierre Préziosi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Safety Monitoring in Group A Meningococcal Conjugate Vaccine Trials: Description, Challenges, and Lessons

Author(s) -

Godwin Enwere,

Gandhali Paranjape,

Prasad S. Kulkarni,

Manisha Ginde,

Katharina Hartmann,

Simonetta Viviani,

Julie Chaumont,

Lionel Martellet,

Marie-Françoise Makadi,

Karen Ivinson,

Elisa Marchetti,

Jacques Hervé,

Kim Kertson,

F. Marc LaForce,

MariePierre Préziosi

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ509

Subject(s) - medicine , context (archaeology) , adverse effect , patient safety , clinical trial , population , intensive care medicine , medical emergency , health care , environmental health , paleontology , economics , biology , economic growth

The determination of the safety profile of any vaccine is critical to its widespread use in any population. In addition, the application of international guidelines to fit local context could be a challenging but important step toward obtaining quality safety data.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research